Navigation Links
Low Acid Coffee Backed By Scientific Research
Date:3/27/2008

WOODLAND, Calif., March 27 /PRNewswire/ -- Puroast(R) Low Acid Coffee has conducted both chemistry and consumer research to confirm its claims that its great tasting, gourmet coffee provides symptom relief for those with stomach problems caused by their morning brew. Puroast(R) achieves this without extractions, substitutes or additives; it uses a natural process that helps ensure the full-bodied taste.

Prior chemistry research at University of California, Davis found Puroast(R) to have less than half the acid of all other commercial coffees. The company now announces first stage results of consumer research that shows nearly 90% of those tested experienced symptom relief when drinking Puroast(R) Low Acid Coffee.

"This is important research for both our company and the consumer," observed Kerry Sachs, co-founder of Puroast(R) Low-Acid Coffee. "When you combine these scientific studies with market data that indicates there are several million consumers who have stomach discomfort from coffee drinking, it's clear Puroast(R) has explosive market potential and delivers a strong consumer benefit."

Arthur R. Euler, MD, a gastroenterologist who directed Glaxo's Zantac(R) Clinical Development Unit, conducted a survey of 250 consumers who came to Puroast(R)'s website looking for a solution to their coffee-related gastrointestinal symptoms. Zantac(R) is a drug used to treat upper gastrointestinal symptoms and is often prescribed by primary care doctors. This research's objective was to evaluate Puroast(R) Low Acid Coffee's effect on these stomach symptoms.

"Our study asked consumers to brew and drink Puroast(R), then compare the symptoms that developed, if any, versus symptoms that developed when they drank other brands of coffee," states Dr. Euler. The survey also asked the participant to evaluate Puroast(R)'s taste. "88% of respondents stated Puroast(R) provided relief of their gut symptoms caused by coffee, and 95% said they would purchase the product again, taste being a key factor. These are extraordinarily high numbers for any product with its target consumer."

Puroast(R) and Dr. Euler are now expanding their study to include seeking input from those consumers who don't experience stomach problems from coffee. This is important for the company as it seeks to achieve "crossover" status - crossover products are those that satisfy both the consumer with the health issue and those only interested in taste. "These expanded studies will help us learn whether Puroast(R) can reach the same level of market penetration of other successful products such as diet sodas, light beer and low-fat yogurt".

Based in Woodland, Calif., Puroast(R) works with grocery retailers in educating the consumer about acid levels in coffee and the effect Puroast(R) Low Acid Coffee can have in reducing their coffee-related stomach discomfort. This effort has resulted in making Low Acid Coffee a new category in the US beverage marketplace.

Puroast(R) Low Acid Coffees can be found at leading grocery and specialty retailers nationwide including Ralph's, Bristol Farms, Albertson's, Publix, Hannaford, Giant Foods, Kroger, King Soopers, D'Agostino's, Sprouts, King Supermarkets, Frys, Mollie Stone's, Ray's, Andronicos, Save Mart and Costco Canada and Chicago.


'/>"/>
SOURCE Puroast
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology
2. Industry Executives Finding Value in Shift of Scientific Publications
3. Childrens Mental Focus Foundation Announces a Scientific Breakthrough for Children Who Have Been Diagnosed With Autism, ADD and ADHD
4. Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
5. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
6. Second Thoughts about Fluoride, Reports Scientific American
7. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
8. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
9. Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes
10. New Risk Factor for Heart Disease Identified in Very Young Children, According to Study at American Heart Association Scientific Sessions
11. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... PurhealthRX , a leading Health and Nutrition Company, is announcing ... full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the ... incorporated into liquid products, while reducing costs to end users. , The team of ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the Law ... organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our ... a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
Breaking Medicine News(10 mins):